Induced pluripotent stem cells for modeling neurological disorders.

Area of Science:

• Stem cell biology
• Neuroscience
• Genetics

Background:

• Induced pluripotent stem cell (iPSC) technology, developed in 2006, has revolutionized disease modeling.
• Advancements in reprogramming efficiency, cell culture, and gene editing have enhanced iPSC applications.
• Neurological disorders particularly benefit from iPSC technology for in vitro generation of central nervous system cells.

Purpose of the Study:

• To review the progress of iPSC-based modeling for various human neurological disorders.
• To highlight the utility of patient-specific iPSC-derived neural cells in understanding disease pathogenesis.
• To discuss the role of iPSC modeling in developing drug screening platforms and identifying therapeutic targets.

Main Methods:

• Utilizing patient-derived induced pluripotent stem cells.
• Differentiating stem cells into specific neural cell types (neurons, glial cells).
• Employing gene editing to create isogenic cell lines for precise mutation analysis.

Main Results:

• iPSC technology allows in vitro recapitulation of neurological disease phenotypes.
• Patient-specific iPSC-derived neural cells provide insights into disease mechanisms.
• Gene editing enhances disease modeling by creating or correcting specific mutations.

Conclusions:

• iPSC technology is a powerful tool for studying neurological disorders like Alzheimer's, Parkinson's, and autism spectrum disorders.
• iPSC-derived neural cells significantly advance our understanding of disease pathogenesis.
• This approach facilitates the development of novel drug screening platforms and therapeutic strategies.